LONG BEACH, Calif. and TORONTO — Glass House Brands Inc. has retained Matt Murphy as an advisor on Drug Enforcement Administration compliance as it relates to instituting regulations related to interstate commerce and the export of medical cannabis compliant with Schedule III regulatory requirements contained in the Controlled Substances Act (CSA).
Murphy is founder and president of Pharma Compliance Group, an advisory firm specializing in providing compliance expertise to pharmaceutical companies. Previously, he served for twenty-six years in the DEA as a special agent and regulatory subject matter expert. He also served as chief of pharmaceutical investigations for the DEA.
Additionally, from 2017 through 2021, Murphy was chief compliance officer for Khiron Life Sciences, the first licensed vertically integrated cannabis operator in Colombia and an early supplier of cannabis flower and extracts to Germany and the UK. During his tenure, he developed Khiron’s compliance and seed-to-sale tracking program.
